- Home
- CDXS vs NKSH Comparison
CDXS vs NKSH Comparison
Compare CDXS & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CDXS | NKSH |
|---|---|---|
| Founded | 2002 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 185.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CDXS | NKSH |
|---|---|---|
| Price | $1.67 | $32.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 12.5K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 4.49% |
| EPS Growth | N/A | ★ 41.35 |
| EPS | N/A | ★ 2.04 |
| Revenue | ★ $52,932,000.00 | $51,980,000.00 |
| Revenue This Year | $15.64 | $2.95 |
| Revenue Next Year | $5.23 | $9.97 |
| P/E Ratio | ★ N/A | $16.45 |
| Revenue Growth | N/A | ★ 19.63 |
| 52 Week Low | $1.52 | $23.75 |
| 52 Week High | $6.08 | $33.92 |
Technical Indicators
Market Signals| Indicator | CDXS | NKSH |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 73.37 |
| Support Level | $1.62 | $29.79 |
| Resistance Level | $1.95 | $30.72 |
| Average True Range (ATR) | 0.10 | 0.92 |
| MACD | 0.03 | 0.40 |
| Stochastic Oscillator | 36.05 | 96.46 |
Price Performance
Historical ComparisonAbout CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.